Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: Does aspirin make a difference?

Circulation

Volumn 116, Issue 3, 2007, Pages 293-297

  Li, Jennifer S ^a,b   Yow, Eric ^b   Berezny, Katherine Y ^b   Rhodes, John F ^a   Bokesch, Paula M ^c   Charpie, John R ^d   Forbus, Geoffrey A ^e   Mahony, Lynn ^f   Boshkov, Lynn ^g   Lambert, Virginie ^h   Bonnet, Damien ⁱ   Michel Behnke, Ina ^j   Graham, Thomas P ^k   Takahashi, Masato ^l   Jaggers, James ^a   Califf, Robert M ^b   Rakhit, Amit ^m   Fontecave, Sylvie ⁿ   Sanders, Stephen P ^o  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f UNIVERSITY OF TEXAS AT DALLAS   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j JUSTUS LIEBIG UNIVERSITY   (Germany)

^k VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^l CHILDREN S HOSPITAL LOS ANGELES   (United States)

^m BRISTOL MYERS SQUIBB   (United States)

ⁿ SANOFI   (France)

^o BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

more..

Author keywords

Aspirin; Heart defects, congenital; Mortality; Shunts; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID;

ARTERY BYPASS; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DEATH; FALLOT TETRALOGY; FONTAN PROCEDURE; HAZARD RATIO; HETEROTAXY SYNDROME; HOSPITALIZATION; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; KAPLAN MEIER METHOD; LOW DRUG DOSE; LUNG ATRESIA; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; NORWOOD PROCEDURE; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PULMONARY ARTERY; RISK; SANO PROCEDURE; SHUNT THROMBOSIS; SURGICAL TECHNIQUE; TRICUSPID VALVE ATRESIA;

ASPIRIN; CARDIAC SURGICAL PROCEDURES; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; PALLIATIVE CARE; PROSPECTIVE STUDIES; PULMONARY ARTERY; TREATMENT OUTCOME;

EID: 34547574052     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.652172     Document Type: Article

References (20)

1. Cobanoglu A, Schultz JM. Total correction of tetralogy of Fallot in the first year of life: late results. Ann Thorac Surg. 2002;74:133-138.
2. Derby CD, Pizarro C. Routine primary repair of tetralogy of Fallot in the neonate. Expert Rev Cardiovasc Ther. 2001;3:857-863.
3. Sivakumar K, Shivaprakasha K, Rao SG, Kumar RK. Operative outcome and intermediate term follow-up of neonatal Blalock-Taussig shunts. Indian Heart J. 2001;53:66-70.
4. Gladman G, McCrindle BW, Williams WG, Freedom RM, Benson LN. The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot's tetralogy in the current era. J Thorac Cardiovasc Surg. 1997;11:25-30.
5. Al Jubair KA, Al Fagih MR, Al Jarallah AS, Al Yousef S, Ali Khan MA, Ashmeg A, Al Faraidi Y, Sawyer W. Results of 546 Blalock-Taussig shunts performed in 478 patients. Cardiol Young. 1998;8:486-490.
6. Ashburn DA, McCrindle BW, Tchervenkov CI, Jacobs ML, Lofland GK, Bove EL, Spray TL, Williams WG, Blackstone EH. Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia. J Thorac Cardiovasc Surg. 2003;125:1070-1082.
7. Sano S, Ishino K, Kado H, Shiokawa Y, Sakamoto K, Yokota M, Kawada M. Outcome of right ventricle-to-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome: a multi-institutional study. Ann Thorac Surg. 2004;78:1951-1958.
8. Checchia PA, McCollegan J, Daher N, Kolovos N, Levy F, Markovitz B. The effect of surgical case volume on outcome after the Norwood procedure. J Thorac Cardiovasc Surg. 2005;129:754-759.
9. Azakie T, Merklinger SL, McCrindle BW, Van Arsdell GS, Lee KJ, Benson LN, Coles JG, Williams WG. Evolving strategies and improving outcomes of the modified Norwood procedure: a 10-year single-institution experience. Ann Thorac Surg. 2001;72:1349-1353.
10. Motz R, Wessel A, Ruschewski W, Bursch J. Reduced frequency of occlusion of aorto-pulmonary shunts in infants receiving aspirin. Cardiol Young. 1999;9:474-477.
11. Centazzo S, Montigny M, Davignon A, Chartrand C, Fournier A, Marchand T. Use of acetylsalicylic acid to improve patency of subclavian to pulmonary artery Gore-Tex shunts. Can J Cardiol. 1993;9: 243-246.
12. McGuirk SP, Griselli M, Stumper OF, Rumball EM, Miller P, Dhillon R, de Giovanni JV, Wright JG, Barron DJ, Brawn WJ. Staged surgical management of hypoplastic left heart syndrome: a single-institution 12-year experience. Heart. 2006;92:364-370.
13. Wells WJ, Yu RJ, Batra AS, Monforte H, Sintek C, Starnes VA. Obstruction in modified Blalock shunts: a quantitative analysis with clinical correlation. Ann Thorac Surg. 2005;79:2072-2076.
14. Jaquiss RD, Ghanayem NS, Hoffman GM, Fedderly RT, Cava JR, Mussatto KA, Tweddell JS. Early cavopulmonary anastomosis in very young infants after the Norwood procedure: impact on oxygenation, resource utilization, and mortality. J Thorac Cardiovascular Surg. 2004;127:982-989.
15. Ghanayem NS, Hoffman GM, Mussatto KA, Cava JR, Frommelt PC, Rubb NA, Steltzer MM, Bevandic SM, Frisbee SS, Jaquiss RD, Litwin SB, Tweddell JS. Home surveillance program prevents interstage mortality after the Norwood procedure. J Thorac Cardiovasc Surg. 2003;126:1367-1377.
16. Nicolas RT, Hills C, Moller JH, Huddleston CB, Johnson MC. Early outcome after Glenn shunt and Fontan palliation and the impact of operation during viral respiratory season: analysis of a 19-year multi-institutional experience. Ann Thorac Surg. 2005;79:613-617.
17. Pitt B, Pepine C, Willerson JT. Cyclooxygenase-2 inhibition and cardiovascular events. Circulation. 2002;106:167-169.
18. Rezkalla SH, Benz M. Antiplatelet therapy from clinical trials to clinical practice. Clin Med Res. 2003;1:101-104.
19. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
20. Tran H, Anand SS. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA. 2004;292:1867-1874.